BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yabe M, Ishibashi K, Onagi A, Tanji R, Honda-Takinami R, Koguchi T, Matsuoka K, Hoshi S, Hata J, Kataoka M, Ogawa S, Hiraki H, Haga N, Kojima Y. Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells. Oncotarget 2018;9:31697-708. [PMID: 30167088 DOI: 10.18632/oncotarget.25851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng R, Wang P, Cao B, Wu M, Li X, Wang H, Chai L. Intestinal response characteristic and potential microbial dysbiosis in digestive tract of Bufo gargarizans after exposure to cadmium and lead, alone or combined. Chemosphere 2021;271:129511. [PMID: 33445016 DOI: 10.1016/j.chemosphere.2020.129511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Dai L, Tao Y, Shi Z, Liang W, Hu W, Xing Z, Zhou S, Guo X, Fu X, Wang X. SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. Front Oncol 2022;12:881801. [DOI: 10.3389/fonc.2022.881801] [Reference Citation Analysis]
3 Li C, Zhang W, Fang T, Li N, Wang Y, He L, He H. Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma. Front Mol Biosci 2021;8:585000. [PMID: 34926570 DOI: 10.3389/fmolb.2021.585000] [Reference Citation Analysis]
4 Kamli H, Owens EP, Vesey DA, Prasanna R, Li L, Gobe GC, Morais C. Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects. Biochem Biophys Res Commun 2022;586:42-8. [PMID: 34826699 DOI: 10.1016/j.bbrc.2021.11.069] [Reference Citation Analysis]
5 Dai L, Li Z, Tao Y, Liang W, Hu W, Zhou S, Fu X, Wang X. Emerging roles of suppressor of cytokine signaling 3 in human cancers. Biomed Pharmacother 2021;144:112262. [PMID: 34607102 DOI: 10.1016/j.biopha.2021.112262] [Reference Citation Analysis]